Arwen Declan

Dr. Arwen Declan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2024 in Academic Emergency Medicine
Verified
Journal Article
Open access
RTR. Andrew Taylor
R. Andrew Taylor
RSRohit B. Sangal
Rohit B. Sangal
MSMoira E. Smith
Moira E. Smith
AHAdrian D. Haimovich
Adrian D. Haimovich
ARAdam Rodman
Adam Rodman
ADArwen Declan
Arwen Declan
Diagnostic errors in health care pose significant risks to patient safety and are disturbingly common. In the emergency department (ED), the chaotic and high‐pressure environment increases the likelihood of these errors, as emergency clinicians must make rapid decisions with limited information, often under cognitive overload. Artificial intelligence (AI) offers promising solutions to improve diagnostic errors in three key areas: information gathering, clinical decision support (CDS), and feedback through quality improvement. AI can streamline the information‐gathering process by automating data retrieval, reducing cognitive load, and providing clinicians with essential patient details quickly. AI‐driven CDS systems enhance diagnostic decision making by offering real‐time insights, reducing cognitive biases, and prioritizing differential diagnoses. Furthermore, AI‐powered feedback loops can facilitate continuous learning and refinement of diagnostic processes by providing targeted education and outcome feedback to clinicians. By integrating AI into these areas, the potential for reducing diagnostic errors and improving patient safety in the ED is substantial. However, successfully implementing AI in the ED is challenging and complex. Developing, validating, and implementing AI as a safe, human‐centered ED tool requires thoughtful design and meticulous attention to ethical and practical considerations. Clinicians and patients must be integrated as key stakeholders across these processes. Ultimately, AI should be seen as a tool that assists clinicians by supporting better, faster decisions and thus enhances patient outcomes.

30 June 2020 in Viruses
Verified
Journal Article
Open access
PDF file
JSJennifer Santos
Jennifer Santos
SBStephanie Brierley
Stephanie Brierley
MGMohit Gandhi
Mohit Gandhi
MCMichael Cohen
Michael Cohen
PMPhillip C. Moschella
Phillip C. Moschella
ADArwen Declan
Arwen Declan
The need for proven disease-specific treatments for the novel pandemic coronavirus SARS-CoV-2 necessitates a worldwide search for therapeutic options. Since the SARS-CoV-2 virus shares extensive homology with SARS-CoV and MERS-CoV, effective therapies for SARS-CoV and MERS-CoV may also have therapeutic potential for the current COVID-19 outbreak. To identify therapeutics that might be repositioned for treatment of the SARS-CoV-2 disease COVID-19, we strategically reviewed the literature to identify existing therapeutics with evidence of efficacy for the treatment of the three coronaviruses that cause severe respiratory illness (SARS-CoV, MERS-CoV, and SARS-CoV-2). Mechanistic and in vitro analyses suggest multiple promising therapeutic options with potential for repurposing to treat patients with COVID-19. Therapeutics with particularly high potential efficacy for repurposing include camostat mesylate, remdesivir, favipiravir, tocilizumab, baricitinib, convalescent plasma, and humanized monoclonal antibodies. Camostat mesylate has shown therapeutic potential, likely by preventing viral entry into epithelial cells. In early research, the targeted antivirals remdesivir and favipiravir appear to benefit patients by decreasing viral replication; clinical trials suggest that remdesivir speeds recovery from COVID-19. Tocilizumab and baricitinib appear to improve mortality by preventing a severe cytokine storm. Convalescent plasma and humanized monoclonal antibodies offer passive immunity and decreased recovery time. This review highlights potential therapeutic options that may be repurposed to treat COVID-19 and suggests opportunities for further research.

1 August 2023 in Advances in Medical Education and Practice
Verified
Journal Article
Open access
PDF file
EWErin Walker
Erin Walker
DNDieu Thao Nguyen
Dieu Thao Nguyen
ABAdam Brockway
Adam Brockway
KRKyle Russi
Kyle Russi
SEShannon Ellis
Shannon Ellis
RCRenee Chosed
Renee Chosed
Introduction: Since the US Medical Licensing Examination (USMLE) Step 1 became Pass/Fall in 2022, medical students competing for residency spots must distinguish themselves with alternative criteria. Research experiences and output offer valuable skill development and objective metrics to support competitive residency applications. Objective: We describe the methodological development of a structured program to support, enhance, and track medical student research efforts at the University of South Carolina School of Medicine Greenville, explain the implementation of the program, and summarize initial program outcomes. Methods: The Student Opportunities for Academic Achievement Through Research in Greenville (SOARinG) Program was established to serve as a centralized hub for rising second year medical student research. The program matched medical students with mentored research projects scheduled during the summer following first-year coursework. The program included a required weekly seminar series on research basics and current biomedical literature. SOARinG culminated with a student research symposium for which students submitted abstracts and presented a poster or a talk. Quantitative and qualitative program outcomes of student and mentor satisfaction with the program were measured through surveys. Results and Discussion: The program was successfully implemented in summers 2021 and 2022. Most students (80– 95%) in each class engaged in mentored summer research projects. Students reported overall satisfaction with research projects and mentor support. Overall, 69% of students rated their overall research experience in the program as extremely good or very good. Each student submitted an abstract and presented at the program’s symposium or alternate research venue. Overall, 97% of research mentors reported that students were adequately prepared for summer research and suggested that students would benefit from additional skills-specific research training. Conclusion: The SOARinG Program provided a formalized process for tracking and showcasing medical student research and allowed for increased student participation in research. Additionally, each participating student produced objective research output, thus enhancing future residency applications.

31 May 2022 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
HVHalee Vaughn
Halee Vaughn
ADArwen Declan
Arwen Declan

22 January 2026 in Applied Clinical Informatics
Verified
Journal Article
Closed access
PDF file
KBKyle Bernard
Kyle Bernard
ADArwen Declan
Arwen Declan
KBKevin Buell
Kevin Buell
EMEric Moyer
Eric Moyer
MGMichael Gottlieb
Michael Gottlieb
Real-world data from vendor-aggregated health information exchanges represent a powerful resource for retrospective clinical research. Epic's Cosmos platform, a large-scale centralized data warehouse, enables querying deidentified electronic health record data. We describe the iterative development of a generalizable clinical informatics workflow for retrospective studies using Cosmos. We applied the Plan-Do-Study-Act cycle to iteratively refine a collaborative research process using Cosmo's SlicerDicer interface, focusing on setting, team, technical preparation, and workflow. We identified multiple areas of improvement to facilitate streamlined collaborative studies. Our institutional review board confirmed Cosmos studies as nonhumans subject research. We expanded collaborations across institutions. We identified key insights for team definition across clinical, research, and skill domains. We expanded our team based on technical skills, domain expertise, and educational aims. We optimized query building and cohort construction, data analysis and validation, and communication processes. We clarified and optimized a collaborative workflow across clinical and informatics expertise. Our collaborative approach to secondary data analysis in Cosmos supports the development of meaningful clinical evidence to support high-quality, well-evidenced patient care. This study demonstrates the application of the Plan-Do-Study-Act cycle to a collaborative workflow for clinically focused secondary data analysis. Our approach allows rapid, reproducible cohort construction and analysis, is adaptable across clinical domains, and scales to multiorganizational collaboration. This approach offers a model for others seeking to develop key clinical insights via retrospective studies within the Cosmos data aggregation tool.

11 June 2026 in npj Digital Medicine
Verified
Journal Article
Open access
ADArwen Declan
Arwen Declan
RTR. Andrew Taylor
R. Andrew Taylor
Healthcare organizations must integrate mission-driven values with financial metrics to govern AI systems. We propose the Total Mission Value (TMV) framework, drawing on insights from Balanced Scorecard, Quintuple Aim, and organizational mission priorities. TMV integrates five ethically grounded domains that define TMV in healthcare: Patient Care, Staff Experience, Operations, Economic, and Education and Research. TMV supports aligning AI implementations with healthcare’s core purpose while maintaining economic sustainability.